InvestorsHub Logo

Bright Boy

12/11/22 11:14 AM

#547403 RE: tryn2 #547394

You betcha!!! Northwest could very easily become a " royalty company", leasing rights to biotech companies in the immunotherapy space. A very "low overhead" way to proceed. The "IP" has already been developed and paid for!!

Cheers,

BB

dstock07734

12/11/22 10:54 PM

#547633 RE: tryn2 #547394

My hope too. It is hard to put price tag on a company whose value is immeasurable.

JV is a good idea so that NWBO can focus on the part of training dendritic cells to recognize various type of solid tumors.